BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31291874)

  • 1. Active Nano-targeting of Macrophages.
    Gaspar N; Zambito G; Löwik CMWG; Mezzanotte L
    Curr Pharm Des; 2019; 25(17):1951-1961. PubMed ID: 31291874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and Cancer.
    Ponzoni M; Pastorino F; Di Paolo D; Perri P; Brignole C
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29973487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages.
    Lee WH; Loo CY; Traini D; Young PM
    Expert Opin Drug Deliv; 2015 Jun; 12(6):1009-26. PubMed ID: 25912721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of Hepatic Macrophages by Therapeutic Nanoparticles.
    Colino CI; Lanao JM; Gutierrez-Millan C
    Front Immunol; 2020; 11():218. PubMed ID: 32194546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Particulate systems for targeting of macrophages: basic and therapeutic concepts.
    Moghimi SM; Parhamifar L; Ahmadvand D; Wibroe PP; Andresen TL; Farhangrazi ZS; Hunter AC
    J Innate Immun; 2012; 4(5-6):509-28. PubMed ID: 22722900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions with the macrophages: An emerging targeted approach using novel drug delivery systems in respiratory diseases.
    Mehta M; Deeksha ; Sharma N; Vyas M; Khurana N; Maurya PK; Singh H; Andreoli de Jesus TP; Dureja H; Chellappan DK; Gupta G; Wadhwa R; Collet T; Hansbro PM; Dua K; Satija S
    Chem Biol Interact; 2019 May; 304():10-19. PubMed ID: 30849336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting macrophage subsets for infarct repair.
    Ben-Mordechai T; Palevski D; Glucksam-Galnoy Y; Elron-Gross I; Margalit R; Leor J
    J Cardiovasc Pharmacol Ther; 2015 Jan; 20(1):36-51. PubMed ID: 24938456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances toward More Efficient Targeted Delivery of Nanoparticles in Vivo: Understanding Interactions between Nanoparticles and Cells.
    Polo E; Collado M; Pelaz B; Del Pino P
    ACS Nano; 2017 Mar; 11(3):2397-2402. PubMed ID: 28267316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage-Targeted Therapeutics for Metabolic Disease.
    Peterson KR; Cottam MA; Kennedy AJ; Hasty AH
    Trends Pharmacol Sci; 2018 Jun; 39(6):536-546. PubMed ID: 29628274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-targeted delivery systems for nucleic acid therapy of inflammatory diseases.
    Singh A; Talekar M; Raikar A; Amiji M
    J Control Release; 2014 Sep; 190():515-30. PubMed ID: 24747762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique roles of nanotechnology in medicine and cancer.
    Alam F; Naim M; Aziz M; Yadav N
    Indian J Cancer; 2014; 51(4):506-10. PubMed ID: 26842179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle-mediated drug delivery system for atherosclerotic cardiovascular disease.
    Matoba T; Koga JI; Nakano K; Egashira K; Tsutsui H
    J Cardiol; 2017 Sep; 70(3):206-211. PubMed ID: 28416142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles Targeting Macrophages as Potential Clinical Therapeutic Agents Against Cancer and Inflammation.
    Hu G; Guo M; Xu J; Wu F; Fan J; Huang Q; Yang G; Lv Z; Wang X; Jin Y
    Front Immunol; 2019; 10():1998. PubMed ID: 31497026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of nanoparticulate systems for macrophage targeting.
    Chellat F; Merhi Y; Moreau A; Yahia L
    Biomaterials; 2005 Dec; 26(35):7260-75. PubMed ID: 16023200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug delivery to macrophages: a review of nano-therapeutics targeted approach for inflammatory disorders and cancer.
    Mukhtar M; Ali H; Ahmed N; Munir R; Talib S; Khan AS; Ambrus R
    Expert Opin Drug Deliv; 2020 Sep; 17(9):1239-1257. PubMed ID: 32543950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active drug targeting: lessons learned and new things to consider.
    Al-Jamal KT
    Int J Pharm; 2013 Sep; 454(1):525-6. PubMed ID: 23558315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanobiotechnology-based drug delivery in brain targeting.
    Dinda SC; Pattnaik G
    Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research progress on the effect of iron oxide nanoparticles in macrophage polarization].
    Zhang H; Zhang X; Feng Y; Du C; Wang Y; Guo X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2023 Apr; 40(2):384-391. PubMed ID: 37139773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The development of novel tumor targeting delivery strategy].
    Gao HL; Jiang XG
    Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat.
    Calvo P; Gouritin B; Villarroya H; Eclancher F; Giannavola C; Klein C; Andreux JP; Couvreur P
    Eur J Neurosci; 2002 Apr; 15(8):1317-26. PubMed ID: 11994126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.